Predicting anti-Kell-mediated hemolytic disease of the fetus and newborn: diagnostic accuracy of laboratory management
American Journal of Obstetrics and Gynecology 2018;219(4):393.e1-393.e8
Slootweg YM, Lindenburg IT, Koelewijn JM, Van Kamp IL, Oepkes D, De Haas M
co-author, author 2 of 6·doi·pubmed
Summary
A sixteen-year cohort of pregnancies with anti-Kell antibodies, drawn from the Dutch national screening programme. The study tests how well repeated titres and the ADCC assay pick out pregnancies at raised risk of haemolytic disease.
Summary based on the published abstract.
- Type
- Retrospective cohort study
- Role
- Co-author, author 2 of 6
- Subjects
- haemolytic disease of the fetus and newborn
- PMID
- 30063902
citeSlootweg YM, Lindenburg IT, Koelewijn JM, Van Kamp IL, Oepkes D, De Haas M. Predicting anti-Kell-mediated hemolytic disease of the fetus and newborn: diagnostic accuracy of laboratory management. Am J Obstet Gynecol. 2018;219(4):393.e1-393.e8. doi:10.1016/j.ajog.2018.07.020